tirzepatide and kidney disease Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide | Clinical Pharmacokinetics

Tirzepatide reduces albuminuria among adults with type 2 diabetes in SURPASS trials

28.50

★★★★☆4.8 (126)

🧬 New data from the SUMMIT trial reveals that long-term tirzepatide (Zepbound) may significantly improve kidney function in patients with obesity, chronic kidney disease (CKD), and heart failure with preserved ejection fraction (

29.84

★★★★★4.9 (98)

Tirzepatide and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management - Abdul‐Hafez - 2026 - Endocrinology, Diabetes & Metabolism

20.20

★★★★★5.0 (157)

Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial

25.13

★★★★★4.7 (84)

Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management

29.94

★★★★★4.9 (203)

SURPASS-4: Tirzepatide slows kidney disease in adults with type 2 diabetes, CV risk

27.59

★★★★★5.0 (176)

This isn't just a weight loss shot… 👀 Tirzepatide is changing the way we think about metabolism, heart health, and even kidney protection. Swipe to see what's really happening inside your body

23.46

★★★★★4.8 (132)